A detailed history of Zions Bancorporation, N.A. transactions in Novartis Ag stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 709 shares of NVS stock, worth $70,247. This represents 0.01% of its overall portfolio holdings.

Number of Shares
709
Previous 892 20.52%
Holding current value
$70,247
Previous $94,000 13.83%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$106.13 - $120.89 $19,421 - $22,122
-183 Reduced 20.52%
709 $81,000
Q2 2024

Aug 08, 2024

SELL
$92.57 - $107.37 $9,164 - $10,629
-99 Reduced 9.99%
892 $94,000
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $6,287 - $7,159
-66 Reduced 6.24%
991 $95,000
Q4 2023

Feb 12, 2024

BUY
$92.27 - $101.54 $922 - $1,015
10 Added 0.96%
1,057 $106,000
Q3 2023

Nov 07, 2023

SELL
$94.73 - $105.13 $8,336 - $9,251
-88 Reduced 7.75%
1,047 $106,000
Q2 2023

Jul 28, 2023

SELL
$92.52 - $104.91 $7,124 - $8,078
-77 Reduced 6.35%
1,135 $114,000
Q1 2023

May 10, 2023

SELL
$80.03 - $92.81 $7,602 - $8,816
-95 Reduced 7.27%
1,212 $111,000
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $1,359 - $1,665
18 Added 1.4%
1,307 $118,000
Q3 2022

Nov 08, 2022

SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 7.2%
1,289 $98,000
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $172,232 - $200,531
-2,139 Reduced 60.63%
1,389 $118,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $52,472 - $59,356
655 Added 22.8%
3,528 $309,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $68,382 - $75,615
858 Added 42.58%
2,873 $251,000
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $17,828 - $20,740
218 Added 12.13%
2,015 $165,000
Q2 2021

Aug 11, 2021

BUY
$85.24 - $94.15 $40,318 - $44,532
473 Added 35.73%
1,797 $164,000
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $15,280 - $18,020
-183 Reduced 12.14%
1,324 $113,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $34,819 - $42,115
-446 Reduced 22.84%
1,507 $142,000
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $24,559 - $27,209
299 Added 18.08%
1,953 $170,000
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $3,965 - $4,463
-49 Reduced 2.88%
1,654 $144,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $69,680 - $97,623
-986 Reduced 36.67%
1,703 $140,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $109,064 - $123,313
-1,293 Reduced 32.47%
2,689 $255,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $1,283 - $1,413
-15 Reduced 0.38%
3,982 $346,000
Q2 2019

Jul 09, 2019

SELL
$75.4 - $92.8 $18,623 - $22,921
-247 Reduced 5.82%
3,997 $365,000
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $7,833 - $8,959
-104 Reduced 2.39%
4,244 $408,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $320,273 - $356,622
4,348 New
4,348 $373,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.